Literature DB >> 12891500

Tissue plasminogen activator for the treatment of intraabdominal abscesses in a neonate.

Ivan R Diamond1, Paul W Wales, Bairbre Connolly, Ted Gerstle.   

Abstract

Fibrinolytic agents have been used successfully in the management of loculated empyema; however, their use in the treatment of intraabdominal abscesses is limited. The authors describe the case of a 4-week-old girl with intraabdominal abscesses secondary to intestinal perforation that were not amenable to percutaneous drainage, but were managed successfully with intracavitary administration of tissue-plasminogen activator. This case represents the first report in a human, in which tissue-plasminogen activator was used to facilitate percutaneous drainage of an intraabdominal abscess. It is also the first time a fibrinolytic agent has been used for this purpose in a child.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12891500     DOI: 10.1016/s0022-3468(03)00275-6

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  3 in total

Review 1.  Use of fibrinolytics in abdominal and pleural collections.

Authors:  Anuradha S Shenoy-Bhangle; Debra A Gervais
Journal:  Semin Intervent Radiol       Date:  2012-12       Impact factor: 1.513

2.  Quality improvement guidelines for pediatric abscess and fluid drainage.

Authors:  Mark J Hogan; Francis E Marshalleck; Manrita K Sidhu; Bairbre L Connolly; Richard B Towbin; Wael A Saad; Ann Marie Cahill; John Crowley; Manraj K S Heran; Eric J Hohenwalter; Derek J Roebuck; Michael J Temple; T Gregory Walker; John F Cardella
Journal:  Pediatr Radiol       Date:  2012-11-02

3.  Tissue-type plasminogen activator prevents formation of intra-abdominal abscesses after surgical treatment of secondary peritonitis in a rat model.

Authors:  Otmar R Buyne; Robert P Bleichrodt; Harry van Goor; Paul E Verweij; Thijs Hendriks
Journal:  Int J Colorectal Dis       Date:  2006-11-07       Impact factor: 2.796

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.